Study of a randomised switch to DTG/RPV in subjects with HIV RNA <50c/ml and archived K103N (Wisard study): week 96 results

AUTHORS

G. Moyle¹, L. Assoumou², J.M. Molina³, F. Post⁴, A. Curran⁵, S. Rusconi⁶, S. De Wit⁷, C. Stephan⁸, F. Raffi⁹, M. Johnson¹⁰, M. Masia¹¹, J. Vera¹², B. Jones¹³, C. Fletcher¹⁴, K. Morris¹⁴, A. Pozniak¹⁵, Wisard Study Group


INSTITUTIONS

¹Chelsea and Westminster NHS Foundation Trust, London, United Kingdom, ²Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France, ³Hospital Saint Louis, Paris, France, ⁴Kings College NHS Foundation Trust, London, United Kingdom, ⁵Hospital Universitario Vall d'Hebron, Barcelona, Spain, ⁶University of Milan, Milan, Italy, ⁷University Hospital of Saint-Pierre, Brussels, Belgium, ⁸Goethe-Universitat Frankfurt, Frankfurt, Germany, ⁹University Hospital of Nantes, Nantes, France, ¹⁰Royal Free London NHS Foundation Trust, London, United Kingdom, ¹¹General University Hospital of Elche, Elche, Spain, ¹²Brighton and Sussex University Hospitals, Brighton, United Kingdom, ¹³ViiV Healthcare, Brentford, United Kingdom, ¹⁴Research Organisation (Kings Cross), London, United Kingdom, ¹⁵Chelsea and Westminster Hospital, London, United Kingdom